TY  - GEN
AU  - Brown,Jacques P
TI  - Antiresorptives: Safety Concerns-Clinical Perspective
SN  - 1533-1601
PY  - 2018///0724
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Bisphosphonate-Associated Osteonecrosis of the Jaw
KW  - pathology
KW  - Bone Density Conservation Agents
KW  - Bone Remodeling
KW  - drug effects
KW  - Clinical Trials, Phase III as Topic
KW  - Denosumab
KW  - Diphosphonates
KW  - Female
KW  - Femoral Fractures
KW  - chemically induced
KW  - Humans
KW  - Incidence
KW  - Observational Studies as Topic
KW  - Osteoporosis
KW  - drug therapy
KW  - Risk Factors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1177/0192623317737066
ER  -